UK Uses Local Outbreak Data To Target Coronavirus Vaccine Trials
Vaccine Frontrunner Is Benefiting From Public-Private Collaboration
The UK Vaccine Taskforce is helping to troubleshoot for COVID-19 candidates including in clinical trials and manufacturing scale-up.
You may also be interested in...
Partnering with AstraZeneca, the Oxford team has opened up a clear lead in the race to enrol thousands of patients for late-stage safety and efficacy trials – but cannot make guarantees of when results might be ready.
The Belgium-Netherlands based company looks on course to gain US approval by the end of 2021.
Sofinnova Raises €445m To Help European Biotechs Reach Critical Mass - And SPACs Are A Welcome Innovation
VC’s new fundraising is oversubscribed, reflecting growing confidence in developing European biotech sector.